A case of fulminant hepatitis cured with the glucagon-insulin treatment

• Published in: Kanzo Vol. 21; no. 10; pp. 1352 - 1357
• Main Authors: HOSOKAWA, Yukio, SUGA, Mitsuo, YOKOYAMA, Yoko, KINOSHITA, Hiroshi, ANZAI, Tetsuro, FUJISAWA, Yasunori, FUJISHIMA, Akira, FUJITA, Hideo, SAITO, Michiko
• Format: Journal Article
• Language: Japanese
• Published: The Japan Society of Hepatology 1980
• Subjects: AFP
• ISSN: 0451-4203; 1881-3593
• DOI: 10.2957/kanzo.21.1352

A 17-year-old male patient with fulminant hepatitis who could be cured with the glucagon-insulin (G-I) treatment is reported. The patient was severely jaundiced (total scrum bilirubin 12.6mg/dl), his serum alanine aminotransferase 828 units, blood ammonia 101μg/dl and both HBs antigen and HBs antibody were simultaneously detected with the radioimmunoassay. Intensive parenteral administrations of prednisolone and l-DOPA, combined with rectal applications of lactulose, proved ineffective in preventing from his Grade III (Adams and Foley) hepatic encephalopathy with asterexis. The G-I treatment was therefore started, which resulted in awakening from coma with a decrease of blood ammonia. During the clinical course, serum AFP level was as high as 782ng/ml, and the liver biopsy specimen obtained after recovery showed cirrhosis of the liver. The mechanism by which the G-I treatment favours the fulminant hepatic disorder was discussed.